Stay updated on SL-401 in BPDCN or AML Clinical Trial
Sign up to get notified when there's something new on the SL-401 in BPDCN or AML Clinical Trial page.

Latest updates to the SL-401 in BPDCN or AML Clinical Trial page
- CheckyesterdayChange DetectedAdded CD4+/CD56+ hematodermic neoplasm as an additional MeSH term for the study.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check22 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check50 days agoChange DetectedAdded Revision: v3.4.2. Removed the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.4%

- Check58 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's current status, with links to cc.nih.gov and opm.gov. Updated the page version from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check65 days agoChange DetectedAdded Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0; removed Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4. These are UI and administrative metadata changes that do not modify the study information or results; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to SL-401 in BPDCN or AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SL-401 in BPDCN or AML Clinical Trial page.